- Survival benefits of warfarin in Korean patients with idiopathic pulmonary arterial hypertension
-
Kang BJ, Oh YM, Lee SD, Lee JS
- KMID: 2381588
- Korean J Intern Med.
- 2015 Nov;30(6):837-845.
- doi: 10.3904/kjim.2015.30.6.837
BACKGROUND/AIMS: Idiopathic pulmonary arterial hypertension (IPAH) is an incurable disease with high mortality. Although most studies recommend anticoagulation treatment for IPAH, the benefits are uncertain, particularly in Korea, where it... -
- CITED
-
- Close
- SHARE
-
- Close
- How Well Does the Target INR Level Maintain in Warfarin-Treated Patients with Non-ValvularAtrial Fibrillation?
-
Kim JH, Song YB, Shin DH, Kim JS, Choi JO, On YK, Kim JS
- KMID: 1782972
- Yonsei Med J.
- 2009 Feb;50(1):83-88.
- doi: 10.3349/ymj.2009.50.1.83
PURPOSE: Although warfarin is an effective oral anticoagulation (OAC) drug to reduce the risk of thromboembolism in patients with non-valvular atrial fibrillation (NVAF), long term follow-up data are scarce to... -
- CITED
-
- Close
- SHARE
-
- Close
- Perioperative Anticoagulation in Patients with Mechanical Heart Valves Undergoing Elective Surgery: Results of a Survey Conducted among Korean Physicians
-
Oh D, Kim S, Lim CY, Lee JS, Park S, Garcia D, Crowther M, Ageno W
- KMID: 2158114
- Yonsei Med J.
- 2005 Feb;46(1):66-72.
- doi: 10.3349/ymj.2005.46.1.66
The optimal perioperative anticoagulation management in patients on warfarin therapy is poorly defined due to the lack of randomized trials. Because guidelines are heterogeneous, it was hypothesized that "treatment strategies... -
- CITED
-
- Close
- SHARE
-
- Close
